NASDAQ | TSX: ACB
Canada’s Leading Medical Cannabis Company Launches Premium Products Redefining Patient Care
EDMONTON, AB, May 8, 2024 /PRNewswire/ – Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the New Zealand market. This new line of premium dried flowers represents a significant milestone in medical cannabis accessibility in New Zealand, an emerging market poised for growth.
The initial product portfolio includes cultivars grown exclusively by Aurora, with each strain meticulously bred and cultivated to address a variety of patient needs. These carefully crafted offerings reflect Aurora’s commitment to providing prescribers and patients with unparalleled quality, potency, and therapeutic benefits.
“As a global leader in medical cannabis, Aurora is…
